Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

67.16 -1.56 (-2.27%)
Official Closing Price Updated: 6:13 PM EDT, Sep 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,909,768
Open 67.86
Bid (Size) 66.26 (3)
Ask (Size) 66.90 (1)
Prev. Close 68.72
Today's Range 65.77 - 68.62
52wk Range 13.53 - 95.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Companies Look to Improved Diagnostic Solutions as a Means to Return to Normalcy
FinancialBuzz.com News Commentary 
From PR Newswire
Canada Exercises Increased Option for 20 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)
Canada exercises increased option for 20 million doses of mRNA vaccine against COVID-19 (mRNA-1273). 
From Business Wire News Releases

Performance

YTD
+249.25%
+249.25%
1 Month
+3.51%
+3.51%
3 Month
+6.70%
+6.70%
6 Month
+160.11%
+160.11%
1 Year
+276.67%
+276.67%

More News

Read More
Coronavirus update: U.S. death toll tops 201,000, as daily tally more than doubles
Tags UK:AZN General PFE
From MarketWatch
Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021
Tags Coronavirus Health Care BNTX
From Benzinga
Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial
Tags MRNA Market News AZN
From Motley Fool
Just 4 in 10 Americans now say they would get a first-generation coronavirus vaccine — and most don’t expect to pay out of pocket
Tags BNTX MRNA AZN
From MarketWatch
Why Inovio Pharmaceuticals Stock Is Down Today
Tags PFE BNTX INO
From Motley Fool
Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine
Tags GSK MRK MRNA
From MarketWatch
Inovio Defies Market-Wide Weakness: What's Behind The Rally?
Tags AZN Benzinga BNTX
From Benzinga
Johnson & Johnson Is Latest To Start Final-Phase Testing For Covid-19 Vaccine
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.